CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Jane Alcorn - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Jane Alcorn

OPENALEX: A5066828201↗ORCID: 0000-0002-3473-2635↗

Affiliations

Organizations

Saskatchewan Health Authorityauthorship · CA University of Saskatchewanauthorship · CA

Public evidence

10 connected articles

A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Protocol2023 · medRxiv Removing barriers to accessing medical cannabis for paediatric patients.2024 · Europe PMC A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol.2024 · Europe PMC Pharmacokinetic of two oral doses of a 1:20 THC:CBD <i>cannabis</i> herbal extract in cats.2024 · Europe PMC Medical cannabis in schools: The experiences of caregivers2023 · PubMed Central Open Access Medical cannabis in schools: A qualitative study on the experiences of clinicians2023 · PubMed Central Open Access Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review.2022 · Europe PMC Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study.2021 · Europe PMC Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD <i>Cannabis</i> Herbal Extract in Dogs.2020 · Europe PMC The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.2018 · Europe PMC

Registered research

Connected studies

A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Trialnct05337033 Cannabidiol in Children With Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study (CARE-E)nct03024827

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.